In-vivo MRI of noradrenergic and dopaminergic nuclei predicts future cognition and Alzheimers disease progression
Noradrenergic and dopaminergic nuclei modulate cognition, and post-mortem data indicate they are affected early in the neurodegenerative cascade of Alzheim